Dr. Li Yanyun (李燕云) — HPV Integrated Management & Cervical Minimally Invasive Surgery | Fudan Cancer Hospital Shanghai
When it comes to the procedural management of HPV-related diseases and cervical conditions, surgical volume is one of the most reliable indicators of expertise. Dr. Li Yanyun (李燕云), Director of the Cervical & Uterine Minimally Invasive Center at Fudan University Cancer Hospital (Shanghai Cancer Center), has performed over 20,000 hysteroscopy and LEEP procedures in the past five years alone — an average of more than 4,000 procedures per year that places her among the highest-volume cervical and uterine minimally invasive surgeons in China. This extraordinary procedural experience, combined with her pioneering development of an integrated management approach for HPV infection across the entire lower genital tract — encompassing the cervix, vulva, and anus — makes Dr. Li a uniquely specialized resource for patients with HPV-related diseases at any anatomical site.
Specialty Focus
- Hysteroscopy: diagnostic and operative, for uterine cavity pathology
- LEEP (loop electrosurgical excision procedure) for cervical precancerous lesions (CIN)
- Cervical cancer and HPV-related cervical disease: comprehensive management
- Integrated lower genital tract HPV management: cervix, vulva, and anus
- Vulvar intraepithelial neoplasia (VIN) and vulvar HPV disease
- Anal intraepithelial neoplasia (AIN) and anal HPV disease
- Minimally invasive gynecologic procedures
Academic & Clinical Titles
- Chief Physician, Director of Cervical & Uterine Minimally Invasive Center, Fudan University Cancer Hospital (Shanghai Cancer Center)
- Over 20,000 hysteroscopy and LEEP procedures performed in the past 5 years
- Pioneer of integrated lower genital tract HPV infection management (cervix, vulva, anus)
20,000+ Procedures: Unmatched Procedural Expertise
The scale of Dr. Li Yanyun's procedural experience — over 20,000 hysteroscopy and LEEP procedures in five years — is extraordinary by any standard. To put this in context: most gynecologists performing these procedures complete a few hundred per year; a high-volume specialist might perform 500–1,000 annually. Dr. Li's volume of more than 4,000 procedures per year represents a level of procedural concentration that is virtually unparalleled.
This volume translates into concrete clinical advantages for patients:
LEEP expertise: LEEP — loop electrosurgical excision procedure — is the standard treatment for CIN II and III, removing the transformation zone of the cervix to eliminate precancerous tissue. The quality of LEEP depends critically on the surgeon's ability to excise the entire transformation zone with adequate margins while removing as little normal cervical tissue as possible. Over 20,000 procedures, Dr. Li has developed the technical precision to achieve this balance consistently — minimizing both the risk of incomplete excision (which leads to recurrence) and the risk of excessive tissue removal (which affects cervical competence and fertility).
Hysteroscopy expertise: Diagnostic and operative hysteroscopy — examination and treatment of the uterine cavity — requires precise instrument control in a confined space. Dr. Li's extraordinary hysteroscopy volume enables her to identify subtle uterine cavity pathology that less experienced operators might miss, and to perform operative procedures (polyp removal, septum resection, adhesion lysis) with the technical fluency that comes only from sustained high-volume practice.
Complication management: With 20,000+ procedures, Dr. Li has encountered and managed the full spectrum of procedural complications — giving her the experience to recognize and address complications promptly when they occur, and the technical skill to minimize their occurrence in the first place.
Integrated Lower Genital Tract HPV Management: A Comprehensive Approach
HPV infection does not respect anatomical boundaries. The same high-risk HPV types that cause cervical cancer can also cause precancerous and cancerous lesions at other lower genital tract sites — including the vulva (vulvar intraepithelial neoplasia, VIN), vagina (vaginal intraepithelial neoplasia, VaIN), and anus (anal intraepithelial neoplasia, AIN). In patients with persistent high-risk HPV infection, multifocal disease — involving more than one anatomical site simultaneously — is not uncommon.
Traditional gynecologic practice has often managed these sites separately, with cervical disease managed by gynecologists, anal disease managed by colorectal surgeons, and vulvar disease managed by dermatologists or gynecologists with varying levels of expertise. This fragmented approach can result in incomplete assessment, delayed diagnosis of non-cervical HPV-related lesions, and suboptimal coordination of treatment across sites.
Dr. Li Yanyun has pioneered an integrated management approach that addresses HPV infection and its consequences across the entire lower genital tract in a single coordinated program. This approach includes:
- Comprehensive lower genital tract examination: Systematic assessment of the cervix, vagina, vulva, and perianal region for HPV-related lesions at each visit
- Coordinated treatment planning: When multifocal disease is present, treatment of all affected sites is planned and sequenced to achieve comprehensive clearance
- Unified follow-up: Post-treatment surveillance covers all lower genital tract sites, ensuring that recurrence or new lesions at any site are detected promptly
- Patient education: Patients are educated about the multifocal nature of HPV infection and the importance of comprehensive surveillance
For patients with HPV-related disease at multiple sites — or for those who have been treated for cervical disease but have not had comprehensive assessment of other lower genital tract sites — Dr. Li's integrated program offers a level of comprehensive care that is not available at most gynecologic centers.
Who Should Consider Consulting Dr. Li Yanyun
- Women with CIN requiring LEEP, particularly those who want the most experienced available operator
- Women with recurrent CIN after prior LEEP who need re-excision with precise margin control
- Women with HPV infection at multiple lower genital tract sites (cervix, vulva, anus) seeking integrated management
- Women with vulvar intraepithelial neoplasia (VIN) or anal intraepithelial neoplasia (AIN) associated with HPV
- Women with uterine cavity pathology (polyps, fibroids, adhesions, septa) requiring hysteroscopic evaluation and treatment
- Women with abnormal uterine bleeding requiring hysteroscopic assessment
- Women who have had incomplete LEEP elsewhere and need expert re-evaluation and re-treatment
How CMCS Connects You with Dr. Li Yanyun
China Medical Concierge Shanghai (CMCS) facilitates access to Dr. Li Yanyun for international patients with HPV-related lower genital tract diseases, cervical precancerous lesions, and uterine cavity conditions. Our team manages the full coordination process — from remote case review and medical record translation to appointment scheduling, interpretation, and in-hospital support.
To begin, patients or their families are encouraged to share available medical records including HPV typing results (with specific genotypes), cervical cytology reports, colposcopy and biopsy histology reports, prior LEEP or treatment records, and any relevant imaging or examination reports for vulvar or anal lesions. Dr. Li's team can conduct an initial remote assessment before any travel to Shanghai is required.
CMCS provides end-to-end support including:
- Medical record translation (English, Arabic, French, and other languages)
- Remote pre-consultation case review
- Appointment coordination with Dr. Li Yanyun at Fudan Cancer Hospital Shanghai
- On-site interpretation during consultations and procedures
- Post-consultation summary and follow-up support
Contact CMCS to Connect with Dr. Li Yanyun
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
CMCS – China Medical Concierge Shanghai connects international patients with Shanghai's leading specialists. We are a health management company, not a hospital. All clinical decisions are made by the treating physician.
0 Kommentare